This meeting is supported by:

OVERVIEW

This is a one day conference hosted at the GSK Medicines Research Centre at Stevenage, UK on 21st June 2024. With the increasing approval of RNA modulating therapies, our speakers will give anyone interested in this topic an excellent opportunity to learn more about this topic. Speakers will cover successful approaches, future opportunities, and novel approaches being explored in industry and academia to exploit ways to downregulate, upregulate or change splicing in protein synthesis for therapeutic purposes. Speakers will also discuss safety and pharmacokinetic aspects of the modalities being explored. The morning session will focus on the use of oligonucleotide approaches to modulating RNA transcription, while the afternoon session will focus on small molecule approaches.

Registration now closed.